"We Envision Growth Strategies Most Suited
to Your Business"

Bone Void Fillers Market Size to Hit USD 3.90 Billion by 2027; Increasing Focus on Novel Product Launches by Key Players to Stimulate Growth

June 18, 2020 | Healthcare

The global bone void fillers market size is expected to gain impetus by reaching USD 3.90 billion by 2027 and exhibiting a CAGR of 5.4% between 2020 and 2027. Fortune Business Insights, in its latest report, titled, “Bone Void Fillers Market Size, Share & Industry Analysis, By Type (Demineralized Bone Matrix (DBM), Collagen Matrix, Calcium Sulfate, Tri-calcium Phosphate, and Others), By Form (Gel, Granules, Paste, Putty, and Others), By End User (Hospitals, Specialty Clinics and Others), and Regional Forecast, 2020-2027.”, observes  that the increasing focus on novel product launches by  the companies is likely to bode well for the market growth during the forecast period. The report further mentions that the market was worth USD 2.80 billion in 2019.


Biocomposites Launches Novel STIMULAN Rapid Cure 3cc


Fierce competition among the market players is occurring extensively and the global bone void fillers market is no exception. Several companies are striving to gain maximum market share and maintain market stronghold during the forecast period. Biocomposites, a leading international medical device manufacturing company, is one such that is consolidating its position by offering novel product to benefit the patients. Recently, in March 2020, the company introduced the new STIMULAN Rapid Cure 3cc. According to the company, the new product is completely absorbable as it is made with calcium sulfate that is beneficial to detect infected, as well as non-infected bone sites. In addition to this, it offers great precision, flexibility, and control for several surgical applications. Michael Harris, CEO of Biocomposites had an interesting take on this development. He said, “Our main aim is to develop and introduce products such as the bone void fillers that drastically improve the way of living of the patients, while limiting hospital visits. We are very proud of our skilled and efficient team involving experts who developed STIMULAN along with the new mini STIMULAN Rapid Cure 3CC. With exciting opportunities ahead, we are trying to expand across the United States and increase our consumer base.”


To get a detailed report summary and research scope of this market, click here:


https://www.fortunebusinessinsights.com/industry-reports/bone-void-fillers-market-101015


Increasing Adoption of Synthetic Products to Bolster Growth


The market report observes that the demand for synthetic bone void fillers is gaining significant pace across the globe. The synthetic products consist of calcium sulfate and tri-calcium phosphate, while offering several advantages over the traditional products. Additionally, they are highly sterile and availability of an infinite supply of raw material is boosting the demand for the product in the market. Furthermore, synthetic bone void fillers offer better success rate, while minimizing risks that are associated with the traditional products. Moreover, synthetic products are devoid of any dangerous risks such as disease transfer that makes them a popular choice. Increasing adoption of synthetic products is likely to drive the market growth during the forecast period.


Innovative Product Launches by the Companies to Spur Demand


Fortune Business Insights provides detailed insights into the highly competitive global market. The companies operating in the market are adopting several strategies, such as novel product launches and development, collaboration, and product expansion offerings to gain a major chunk of the market share between 2020 and 2027. The fiercely competitive marketplace provides many opportunities to the key players to establish themselves and maintain their robust positions.


List of the Companies Operating in the Market:



  • BONESUPPORT AB

  • Wright Medical Group N.V.

  • DePuy Synthes Companies

  • Stryker

  • Arthrex, Inc.

  • Biocomposites

  • Zimmer Biomet

  • Collagen Matrix, Inc.

  • Pacific Bioceramics

  • Others


Further Report Findings:



  • The market in North America was worth USD 1.31 billion in 2019 and is likely to hold the largest global market revenue in the forthcoming years. This is ascribable to factors such as competitive pricing of the bone void fillers and increasing adoption of technologically advanced products in the region.

  • Europe, on the other hand, is expected to be the second-most leading region owing to the presence of numerous emerging companies such as BONESUPPORT AB and others.

  • The demineralized bone matrix (DBM) segment based on type held a market share of 32.9% in 2019 and is expected to rise gradually during the projected horizon. This is attributable to their possession of several advantages such as reliability and safety that is further driving the demand for DBM.

  • The hospitals segment based on end user is likely to show significant growth owing to their high dependency for performing orthopedic procedures that involve administration of these void fillers.


Table of Segmentation:











































 ATTRIBUTE



 DETAILS



Study Period



  2016-2027



Base Year



  2019



Forecast Period



  2020-2027



Historical Period



  2016-2018



Unit



  Value (USD billion)



Segmentation



By Type



  • Demineralized Bone Matrix (DBM)

  • Collagen Matrix

  • Calcium Sulfate

  • Tri-calcium Phosphate

  • Others



By Form



  • Gel

  • Granules

  • Paste

  • Putty

  • Others



By End User



  • Hospitals

  • Specialty Clinics

  • Others



By Geography



  • North America (U.S. and Canada)

  • Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, and Rest of Asia-Pacific)

  • Latin America (Brazil, Mexico, and Rest of Latin America)

  • The Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa)


Bone Void Fillers Market
  • PDF
  • 2019
  • 2016-2018
  • 135

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Our Clients

iqvia
UBS
Oecc
Daikin
Ansell
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X